SEC Form 4 · accession 0001808968-26-000017
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew B. Klein
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Aug 4, 2026
Accepted (ET)
Aug 6, 2026 · 5:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 4, 2026 | S | 10,292 | $68.57 | D | 383,868 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of the 25,000 RSUs from an August 1, 2025 grant of 75,000 RSUs.
- F2Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026.